Patent 9445994 was granted and assigned to Massachusetts Institute of Technology on September, 2016 by the United States Patent and Trademark Office.
The invention provides delivery systems comprised of stabilized multilamellar vesicles, as well as compositions, methods of synthesis, and methods of use thereof. The stabilized multilamellar vesicles comprise terminal-cysteine-bearing antigens or cysteine-modified antigens, at their surface and/or internally.